RxDoctor Payments Data

Suhag Patel

Physician Assistant · Williamsport, PANPI 1891305579

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $11,700 of the $19,235 with a category attached, or 60.8%. AbbVie accounts for 67.7% of it on its own, with 18 other manufacturers making up the rest. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,235in general payments, 2019–2025

Across 141 payments — averaging $136.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$13K
  • Livanova USA, Inc.$1K
  • EMD Serono, Inc.$792
  • Nevro Corp.$720
  • Novartis$677
  • Pfizer$445
  • plus $3K from 13 others

What the payments were for

  • Speaking & faculty fees$11,70061%
  • Travel & lodging$4072%
  • Food & beverage$7,10337%
  • Education$250%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,235 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab35$330,110
Nurtec OdtRimegepant Sulfate213$288,233
Emgality PenGalcanezumab-Gnlm213$185,395
Aimovig AutoinjectorErenumab-Aooe117$90,725
Glatiramer Acetate14$80,447
UbrelvyUbrogepant57$55,367
GlatopaGlatiramer Acetate21$52,150
LamictalLamotrigine24$41,105
EpidiolexCannabidiol (Cbd)13$39,728
Ajovy AutoinjectorFremanezumab-Vfrm42$33,844
QuliptaAtogepant28$33,485
NeuproRotigotine16$18,243
NamzaricMemantine Hcl/Donepezil Hcl11$14,163
Rivastigmine58$13,906
TopamaxTopiramate11$13,004

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt, Dilantin$445$292,775225 claims
AbbVieUbrelvy, Qulipta, Namzaric$13,016$103,01696 claims
UCB, Inc.Neupro$125$18,24316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Williamsport

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →